Business Description
Spexis AG
ISIN : CH0106213793
Share Class Description:
XSWX:SPEX: Registered SharesCompare
Compare
Traded in other countries / regions
SPEX.SwitzerlandSPEXz.UK29Y.GermanyPPHOF.USA IPO Date
2018-05-15Description
Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.45 | |||||
| Debt-to-EBITDA | -0.7 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 60.3 | |||||
| 3-Year EPS without NRI Growth Rate | 59.8 | |||||
| 3-Year FCF Growth Rate | 63.5 | |||||
| 3-Year Book Growth Rate | -56.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.49 | |||||
| 9-Day RSI | 36.66 | |||||
| 14-Day RSI | 35.83 | |||||
| 6-1 Month Momentum % | -63.33 | |||||
| 12-1 Month Momentum % | -81.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.57 | |||||
| Quick Ratio | 0.57 | |||||
| Cash Ratio | 0.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -62.8 | |||||
| Shareholder Yield % | 15.81 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -59.2 | |||||
| ROA % | -37.61 | |||||
| ROIC % | -44.98 | |||||
| ROC (Joel Greenblatt) % | -692.6 | |||||
| ROCE % | -45.79 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.17 | |||||
| EV-to-EBIT | -0.87 | |||||
| EV-to-Forward-EBIT | -0.58 | |||||
| EV-to-EBITDA | -0.98 | |||||
| EV-to-Forward-EBITDA | -0.58 | |||||
| EV-to-Forward-Revenue | 4.72 | |||||
| EV-to-FCF | -1.36 | |||||
| Earnings Yield (Greenblatt) % | -114.94 | |||||
| FCF Yield % | -211.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spexis AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | |||
| EPS (TTM) (CHF) | -0.25 | ||
| Beta | 1.69 | ||
| Volatility % | 775.98 | ||
| 14-Day RSI | 35.83 | ||
| 14-Day ATR (CHF) | 0.011615 | ||
| 20-Day SMA (CHF) | 0.06444 | ||
| 12-1 Month Momentum % | -81.62 | ||
| 52-Week Range (CHF) | 0.0122 - 1.06 | ||
| Shares Outstanding (Mil) | 67.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spexis AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spexis AG Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Spexis AG Frequently Asked Questions
What is Spexis AG(XSWX:SPEX)'s stock price today?
The current price of XSWX:SPEX is CHF0.06. The 52 week high of XSWX:SPEX is CHF1.06 and 52 week low is CHF0.01.
When is next earnings date of Spexis AG(XSWX:SPEX)?
The next earnings date of Spexis AG(XSWX:SPEX) is .
Does Spexis AG(XSWX:SPEX) pay dividends? If so, how much?
Spexis AG(XSWX:SPEX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers